According to filings with the U.S. Securities and Exchange Commission, RxLightning is raising $17,499,950.00 in new funding. Sources indicate that as part of senior management President, Julia Regan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About RxLightning
Healthcare providers no longer have to go to multiple portals or chase down the appropriate paperwork to complete the enrollment process. RxLightning serves as a single destination for healthcare providers to enroll patients for any specialty medication, brand or generic, at any specialty pharmacy. We strive to improve speed of access for patients to specialty medications, accelerating the delivery of your specialty products and maximizing your revenue stream. Our platform is a single solution that simplifies, streamlines and automates the complex manual process of specialty medication enrollment across manufacturers, hubs and specialty pharmacies. Specialty prescribing is complex. We make it simple. Digitized forms for 900+ specialty medications to get your patients started on the therapies they need with RxLightning speed.

To learn more about RxLightning, visit http://www.rxlightning.com/

Contact:
Julia Regan, President
855-485-0579

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.